SUPERNUS PHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q3 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2012 to Q3 2023.
  • Supernus Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2023 was 1.69 %, a 25% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2022 was 3.61 %, a 6.81% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2021 was 3.38 %, a 62.1% decline from 2020.
  • Supernus Pharmaceuticals, Inc. annual Return On Assets for 2020 was 8.92 %, a 14.1% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 1.69 -0.56 -25% Jul 1, 2023 Sep 30, 2023
Q2 2023 2.68 -0.82 -23.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 3.02 -1.52 -33.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 3.61 +0.23 +6.81% Oct 1, 2022 Dec 31, 2022
Q3 2022 2.24 -3.08 -57.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 3.5 -3.08 -46.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 4.54 -2.85 -38.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 3.38 -5.54 -62.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 5.33 -4.34 -44.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 6.58 -2.98 -31.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 7.39 -2.89 -28.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 8.92 -1.46 -14.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 9.67 -0.48 -4.73% Jul 1, 2020 Sep 30, 2020
Q2 2020 9.55 -0.97 -9.22% Apr 1, 2020 Jun 30, 2020
Q1 2020 10.3 -0.62 -5.69% Jan 1, 2020 Mar 31, 2020
Q4 2019 10.4 -2.03 -16.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 10.1 -2.92 -22.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 10.5 -3.42 -24.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 10.9 -3.9 -26.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 12.4 -3.09 -19.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 13.1 -3.94 -23.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 13.9 -18.9 -57.6% Apr 1, 2018 Jun 30, 2018
Q1 2018 14.8 -19.3 -56.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 15.5 -20.7 -57.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 17 -20.8 -55% Jul 1, 2017 Sep 30, 2017
Q2 2017 32.9 +19.4 +144% Apr 1, 2017 Jun 30, 2017
Q1 2017 34.1 +23.8 +232% Jan 1, 2017 Mar 31, 2017
Q4 2016 36.2 +27.6 +321% Oct 1, 2016 Dec 31, 2016
Q3 2016 37.8 +30.5 +418% Jul 1, 2016 Sep 30, 2016
Q2 2016 13.5 +10.2 +307% Apr 1, 2016 Jun 30, 2016
Q1 2016 10.3 +5.93 +137% Jan 1, 2016 Mar 31, 2016
Q4 2015 8.6 +18.2 Oct 1, 2015 Dec 31, 2015
Q3 2015 7.29 +42 Jul 1, 2015 Sep 30, 2015
Q2 2015 3.3 +58.5 Apr 1, 2015 Jun 30, 2015
Q1 2015 4.32 +81.4 Jan 1, 2015 Mar 31, 2015
Q4 2014 -9.62 +73.2 +88.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -34.7 +43.1 +55.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -55.2 +23 +29.5% Apr 1, 2014 Jun 30, 2014
Q1 2014 -77 -7.76 -11.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -82.8 -17.6 -27.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -77.8 -158 -196% Jul 1, 2013 Sep 30, 2013
Q2 2013 -78.2 Apr 1, 2013 Jun 30, 2013
Q1 2013 -69.3 Jan 1, 2013 Mar 31, 2013
Q4 2012 -65.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 80.7 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.